A multi-agency crackdown is finally taking shape to stem the diversion of NDPS drugs into open market, and rampant abuse
Ambika Sharma
Every third drug in the Indian domestic market is manufactured in Himachal Pradesh and the state’s pharmaceutical industry is pegged at Rs 8000 crore.
Of the 625 manufacturers in the pharma hubs, 139 have been given licences to produce pharma-opioids/psychotropic substances, listed in the schedule of the Narcotic Drugs and Psychotropic Substances (NDPS) Act.
In the absence of any nationwide survey to gauge an estimate of genuine users of these narcotic and psychotropic drugs, meant for therapeutic purposes, the pharmaceutical companies continue to upscale manufacturing to cater to the ever-increasing demand for recreational purposes.
This illegal diversion for the nefarious use of a sizeable chunk of pharma-opioids has besmirched the image of Himachal’s pharma hubs, which prided themselves in manufacturing Covid vaccines and medicines in recent months.
The latest case of a Baddi-based wholesale trader, Zannet Pharmaceuticals, indulging in illegal sale amounting to Rs100 crore of narcotic drugs like Nitrazapem, Codeine and Etizolam through fake bills and firms has exposed the chinks in the open-ended licensing policy.
That the trader’s wholesale drug licence had been cancelled in Punjab in 2018-19 and the Rajasthan drug control administration did not bother to provide details regarding the firm to the local authorities expose glaring loopholes in the system.
Several such cases have also surfaced in Paonta Sahib and Kala Amb in Sirmaur district, facilitating the illegal entry into the market of pharma opioids like Tramadol in Punjab and other states, with sales running into crores.
There are 14 NDPS drugs which are manufactured for therapeutic use, of which three — Alprazolam, Codeine and Tramadol — are widely misused for recreational purposes and by addicts, as per the seizure pattern of the police.
Licence loophole
Instead of devising a stringent licensing system that ensures restricted and controlled production, the open-ended system results in units manufacturing tablets coming out with scheduled NDPS drugs as well.
The absence of effective inter-state and inter-departmental coordination further fuels sales, as departments like State Taxes and Excise and Directorate General of Goods and Service Tax Intelligence have little or no coordination with the Drug Control Authority (DCA).
The DCA did wake up after the anomalies came to fore during cases unearthed recently in Baddi, Kala Amb and Paonta Sahib.
To read the full article click on the link below:
https://www.tribuneindia.com/news/features/tracing-himachals-illegal-drug-trade-349284